0000950170-24-078167.txt : 20240627 0000950170-24-078167.hdr.sgml : 20240627 20240627082637 ACCESSION NUMBER: 0000950170-24-078167 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20240626 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year FILED AS OF DATE: 20240627 DATE AS OF CHANGE: 20240627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Singular Genomics Systems, Inc. CENTRAL INDEX KEY: 0001850906 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 812948451 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40443 FILM NUMBER: 241075448 BUSINESS ADDRESS: STREET 1: 3010 SCIENCE PARK ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 333-7830 MAIL ADDRESS: STREET 1: 3010 SCIENCE PARK ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 8-K 1 omic-20240626.htm 8-K 8-K
12/31false000185090600018509062024-06-262024-06-26

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 26, 2024

 

 

Singular Genomics Systems, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware

001-40443

81-2948451

(State or other jurisdiction
of incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

3010 Science Park Road
San Diego, California 92121

 

(858) 333-7830
(Registrant’s address of principal executive offices

and telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of Each Class

 

Trading
Symbol(s)

 


Name of Each Exchange on Which Registered

Common Stock, par value $0.0001 per share

 

OMIC

 

Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 


 

 

 

 

Item 5.03 Amendment to Articles of Incorporation or Bylaws; Changes in Fiscal Year.

At the 2024 Annual Meeting of Stockholders of Singular Genomics Systems, Inc. (the “Company”) held virtually on May 29, 2024 (the “Annual Meeting”), the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company’s issued and outstanding common stock (the “common stock”) at a ratio of between 1-for-10 and 1-for-30 shares, with the final ratio to be selected by the Company’s Board of Directors (the “Reverse Stock Split”). Following the receipt of stockholder approval at the Annual Meeting, the Board of Directors approved a final ratio of 1-for-30 shares such that every 30 shares of common stock are combined and reclassified into one share of common stock.

On June 25, 2024, the Company filed a certificate of amendment (the “Reverse Stock Split Amendment”) to the Company’s Amended and Restated Certificate of Incorporation with the Secretary of State of Delaware to effect a 1-for-30 Reverse Stock Split of the common stock, which became effective at 12:01 a.m. Eastern Time on June 26, 2024. The Reverse Stock Split Amendment does not reduce the number of authorized shares of common stock, which remains at 400,000,000, and does not change the par value of the common stock, which remains at $0.0001 per share. The Reverse Stock Split does not reduce the number of shares of the Company’s Series A Preferred Stock outstanding, which remains at 2,500 shares but is subject to a proportional conversion ratio adjustment. Additionally, the Company’s outstanding equity-based awards and other outstanding equity rights were proportionately adjusted. The Reverse Stock Split was effective for purposes of trading on the Nasdaq Capital Market as of the opening of business on June 26, 2024. The CUSIP number for the common stock following the Reverse Stock Split is 82933R308.

As a result of the Reverse Stock Split, every 30 shares of common stock were combined into one issued and outstanding share of common stock and no fractional shares were issued. Instead, to any record holder who was otherwise entitled to receive a fractional share of common stock, the Company issued such holder an additional fractional share such that, when combined with the fractional share otherwise issuable as a result of the Reverse Stock Split, equaled a whole share of common stock. As provided in the Company’s press release issued on June 21, 2024, stockholders owning shares via a bank, broker or other nominee will have their positions automatically adjusted to reflect the reverse stock split and will not be required to take further action in connection with the reverse stock split, with such adjustment subject to each bank, broker or other nominee’s particular processes. The Reverse Stock Split reduced the number of shares of common stock outstanding from approximately 74.7 million to approximately 2.5 million shares.

The foregoing description of the Reverse Stock Split Amendment does not purport to be complete and is qualified in its entirety by reference to the complete text of the Reverse Stock Split Amendment, a copy of which is filed with this report as Exhibit 3.1 and is incorporated herein reference.

 

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit

Number

 

Description

3.1

 

Certificate of Amendment to Amended and Restated Certificate of Incorporation.

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Singular Genomics Systems, Inc.

 

 

 

 

Dated:

June 27, 2024

By:

/s/ Dalen Meeter

 

 

 

Dalen Meeter
Chief Financial Officer
Principal Financial Officer and Principal Accounting Officer

 

 

 EX-3.1 2 omic-ex3_1.htm EX-3.1 EX-3.1

 

Exhibit 3.1

CERTIFICATE OF AMENDMENT

to the

AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

of

SINGULAR GENOMICS SYSTEMS, INC.

Singular Genomics Systems, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY:

FIRST: The name of the Corporation is Singular Genomics Systems, Inc. The Amended and Restated Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on June 1, 2021.

SECOND: That the Board of Directors of the Corporation duly adopted resolutions setting forth a proposed amendment to the Amended and Restated Certificate of Incorporation of the Corporation, as amended to date, in the form set forth below (the “Amendment”), declaring the Amendment to be advisable and directing that the Amendment be submitted to the stockholders of the Corporation for consideration thereof at the annual meeting:

RESOLVED, that the introductory paragraph of Article Fourth of the Amended and Restated Certificate of Incorporation of the Corporation, be, and it hereby is, amended to insert the following at the end of such paragraph:

Upon the effectiveness of the filing (the “Effective Time”) of this Certificate of Amendment to the Restated Certificate of Incorporation of the Corporation, pursuant to Section 242 of the General Corporation Law of the State of Delaware, the shares of Common Stock of the Corporation issued and outstanding immediately prior to the Effective Time (the “Old Common Stock”), shall automatically without further action on the part of the Corporation or any holder of Old Common Stock, be reclassified, on a one-for-30 basis, into fully paid and nonassessable shares of Common Stock, par value $0.0001 per share (the “New Common Stock”), such that each thirty (30) shares of Old Common Stock will be reclassified as one (1) share of New Common Stock, subject to the treatment of fractional share interests as described below (the “Reverse Stock Split”). From and after the Effective Time, each holder of a certificate or certificates which immediately prior to the Effective Time represented outstanding shares of Old Common Stock (the “Old Certificates”) shall be entitled to receive a certificate or certificates (the “New Certificates”) representing the shares of New Common Stock into which the shares of Old Common Stock formerly represented by such Old Certificates have been reclassified pursuant to this Certificate of Amendment. Until surrender, each Old Certificate will be deemed to represent the number of shares of New Common Stock into which such shares of Old Common Stock shall have been reclassified pursuant to this Certificate of Amendment. If, as a result of the Reverse Stock Split, any holder would otherwise be entitled to receive a fractional share of New Common Stock, the Corporation shall cause to be issued to such holder an additional fractional share of New Common Stock that, when combined with the fractional share otherwise issuable to such holder as a result of the Reverse Stock Split, equals a whole share of New Common Stock, such that no fractional shares result from the Reverse Stock Split.

THIRD: That thereafter, pursuant to resolution of its Board of Directors, the annual meeting of the stockholders of the Corporation was duly called and held upon notice in accordance with Section 222 of

the General Corporation Law of the State of Delaware, at which meeting the necessary number of shares as required by statute were voted in favor of the Amendment.

FOURTH: That said Amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

FIFTH: That this Certificate of Amendment to the Amended and Restated Certificate of Incorporation shall become effective as of 12:01 a.m. Eastern Time on June 26, 2024.

****


 

IN WITNESS WHEREOF, this corporation has caused this Amendment to the Amended and Restated Certificate of Incorporation to be signed by its duly authorized officer and the foregoing facts stated herein are true and correct.

Dated: June 25, 2024

SINGULAR GENOMICS SYSTEMS, INC.

By: /s/ Dalen Meeter
Name: Dalen Meeter
Title: Chief Financial Officer

 EX-101.SCH 3 omic-20240626.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Central Index Key Entity Central Index Key Entity Address, State or Province Entity Address, State or Province Cover [Abstract] Entity Address, Address Line One Entity Address, Address Line One Amendment Flag Amendment Flag Entity Interactive Data Current Entity Interactive Data Current Document Quarterly Report Document Quarterly Report Entity Address, City or Town Entity Address, City or Town Document Type Document Type Title of 12(b) Security Title of 12(b) Security Document Fiscal Period Focus Document Fiscal Period Focus Soliciting Material Entity Address, Address Line Two Entity Address, Address Line Two Document Period End Date Document Period End Date Trading Symbol Trading Symbol Pre-commencement Tender Offer Security Exchange Name Security Exchange Name Written Communications Entity Ex Transition Period Entity Ex Transition Period Pre-commencement Issuer Tender Offer Entity Filer Category Entity Filer Category Current Fiscal Year End Date Current Fiscal Year End Date Entity Registrant Name Entity Registrant Name Entity Emerging Growth Company Entity Emerging Growth Company Securities Act File Number Entity File Number Entity Shell Company Entity Shell Company Entity Tax Identification Number Entity Tax Identification Number Entity Current Reporting Status Entity Current Reporting Status Document Fiscal Year Focus Document Fiscal Year Focus City Area Code City Area Code Local Phone Number Local Phone Number Document Transition Report Document Transition Report Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Information, Former Legal or Registered Name Entity Small Business Entity Small Business XML 5 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Document and Entity Information
Jun. 26, 2024
Cover [Abstract]  
Entity Registrant Name Singular Genomics Systems, Inc.
Entity Central Index Key 0001850906
Document Type 8-K
Entity Information, Former Legal or Registered Name N/A
Document Period End Date Jun. 26, 2024
Amendment Flag false
Current Fiscal Year End Date --12-31
Entity Emerging Growth Company true
Entity Ex Transition Period false
Trading Symbol OMIC
Entity File Number 001-40443
Entity Tax Identification Number 81-2948451
Entity Address, Address Line One 3010 Science Park Road
Entity Address, City or Town San Diego
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92121
City Area Code 858
Local Phone Number 333-7830
Written Communications false
Soliciting Material false
Pre-commencement Issuer Tender Offer false
Pre-commencement Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001 per share
Security Exchange Name NASDAQ
Entity Incorporation, State or Country Code DE
EXCEL 6 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 7 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 8 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 25 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports omic-20240626.htm omic-20240626.xsd http://xbrl.sec.gov/dei/2024 false false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "omic-20240626.htm": { "nsprefix": "omic", "nsuri": "http://singulargenomics.com/20240626", "dts": { "inline": { "local": [ "omic-20240626.htm" ] }, "schema": { "local": [ "omic-20240626.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] } }, "keyStandard": 25, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2024": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 37, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 25 }, "report": { "R1": { "role": "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_7ba62069-82e7-407a-890d-2aad88914176", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "omic-20240626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_7ba62069-82e7-407a-890d-2aad88914176", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "omic-20240626.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r6" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "terseLabel": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r7" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r10" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Securities Act File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "terseLabel": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r1" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInformationFormerLegalOrRegisteredName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInformationFormerLegalOrRegisteredName", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Information, Former Legal or Registered Name", "documentation": "Former Legal or Registered Name of an entity" } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r8" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "terseLabel": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r1" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "terseLabel": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://singulargenomics.com/20240626/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r9" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 13 0000950170-24-078167-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-078167-xbrl.zip M4$L#!!0 ( %)#VUBD(#,8+1< $JT 1 ;VUI8RTR,#(T,#8R-BYH M=&WM/6M3(SF2W_=7:)G;'3H.V?5^&+HW&*!GN9FF.S 3,W=?-E22"M=VN]^ M>D?.DSA*)/GCI\M?R6G*AWV9%(227E$,.NWV:#1JB3!*\C0>%C!6WN)IOTTH MK3H_R23#[\DI*R3I&)IA41W#Z!A>RW==X[\UK:-I4\W2P3B+KGL% MV>?O"+:"L9-$QO&8?(P2EO"(Q:1;#WH L^0M12YC*[D:)5]MDK M !V DB1_OS7,""/3V'Y]^[?*> M[#-Z%W0A[V _E[QUG=ZTH:"-_-! DJ>6H;O+L%K6J!ND_2DHXUQW#J%IS%58M\EL"&V<8RZ "YD.HM?8+?@L*,9V950S!!;[O(6)*' M:=97'2#V;:IYU)SN9SYDRSHQ#*H95&_F/RRRA>CQVU"Z]^$OY*@GF8#?Y*B( MBEA^\.@O1^WR3_RR+PNFUCR5?PZCF_=[)VE2@"2@5T#V/<++3^_W"GE;M-5* M:F.G[:K7HR 58Y(7XUB^W^L#OJ.D0]BP2/\:]0=I!J0O#@=,H'CJ$&]P>[BG M1A713=U(1/D@9F-D10FE1]%M!_N66?EG)(1,U)\37B61>+_W\5]IKA469K3)J.XQH,4)6P/HXBH\[),,L EH\@!UG\OY)E9XE Z55! M>5MKXFJ,&8\#Q?MW07^BT)\WX/*-D1T OM M0R<]*MAX[X-NM$W]J#TSZ?DP2#V0 6,:]05(3TMW=.K93D@U30M"W_*T@%O3 M,!R#E!8HJ3_&[/I)$_\0LCB7CYJ<81F!;KLHV V=6J9E4I]S3G4F--,(8=K: MS.3.$N"K\0G,+F/Q>2+D[2]R_+1) ORZ9VN^YMR;:7N6+3(92B KE_F'(Y2$ MG5P)'AB-*,G80?GU?B\'?HQ1"JGO>AE.!B4#K85"ZS87P-NJ^^D^U<<\'6;J MDY+TG0HBA:;'0E0UE0I']:=(X.S OG]0Z.LFZXF9=JZ@O023K*V.#PSMA+AX.Q1I$H>ITP*F@E8F&0O_^@.]KA M41O' BP-IC#5@%A!CC 9+<,>%$2DPR"6Y =-_;L[CS>/@QGH%P-GMUS[H2$7 M0\AA<)G=A9&G<9IU:L0NAGA42SCJ7];6T\W(B)\K-B$0([FD@T MRZ5JHO8D:NPWQO*PG)FN:2U8$U4#0$C,!KGLY'+ ,K#%RTTU])[57=]$>11$,>P%.G7M MJA+4$LTBJCO_VZ':U4-AN\CN]E79X(K2<[$_@FG1()/L:T?]I/C%G 5\=_A9 MDU_3P<2_D5D1P>Z\:@@E&['O9Z0-#&WXGJ-/_8.9;(0M%_&:\J$"QUQ*])F0 M_?JS9+"EDGE!Y TZ9S-5+,6[SHRBG*_T?-_W0M^V*0\-#[TC 2@PVZ&!87B^ M&=C<"\2ZE-X7M0=LW"GS72/8#-TC= Q@49EL$)__,TPDP2WK>NSA1<,<* ?V MPTH65I6865[P&Y?Z4[7OJAN=[T#_?MM[VW4;%Y.A#.MI)K7'_, 1W*<.TRQJ M>2ZG ;="&H2NT,+0DLPWGRM=2G?BI;R.(%TQWDA^U6\:D6S>S'AS>VR*MTGHFO_[):!28241:V6-10E+"?Y0')T8@H2 M)20J<@)&%"BY[-WS=RFK&N4[.;G%IY?@S.J-0<;F@![/"0;.L@]<C*TJ2EU[G./PT]K/72[8K?G5<24JV6Z M<2)Z.C5\R[-L_0E[Q#E2W=U6H>YNA&$V09)])9O1BY<6/9F1?P^S*!>18O]&?*P/$F NG"ND1KP-K;>#=@?M#MK5[!Q__7:.O%[#T/<9=RP:.+H&QB_8O;[C>E03OB.DS4PGL-=C,!\+D8=HE^<*RKX!%)AXPG-?GVT2,+YK:PN2J1Q%,TPW--L(GIU],D.P$_CS1O$ZW@D('#V0. M+2&/[7/=-7Q.-18:U/*80YDP7"H=YOI!X#N^ZZ^5/&H'\CG[DJ4WD3H8\7K. MH1.01C!Z$C&R AD?A5;! ]?0-4Z9HX?4TCU JVYP"IM][NB&'FIVL%:T?DD! M;_'_10/E<=LZ5I.2@O6^I=27Q\GQ_2?+ M&YU9S' ],(M,!^2-#"7UO%"CIND%CNV9OO%\5S\JUF.@_88EC&=[6Z%4WSU= MJ6JV8W/-\JA@9D MWS0ITS2P>83MVAJSO- -GTN-7U-80E]Z:;)Y;[P)\W<] M4]LP65:V/Y]'>V_90IRD7?S]!\_0W<.H;[F<6DPS0 \+077/TSEC(?SGKBODWIR-_@A_R.Q7 M>CE7+JD$: *!E *\Z[3&5NCB$?H"%DW%=%H(V2D?8#GTW$89*\\YSK+;G M(8DLX@A%PBC! &6'6BW7\O_6Z*%R,;5LTURVGIRGIZ7.8YH5@%WD8L4C_+"I MH*'#8?-G\H!ZH?!@+RA"P]!Y:/)G*YW?LZ@ U&(RY_)O%Y07!QPFUY] 6H+(C'?,NVK:?X-"TJ]P>)]S=8M1W9ABWIEC@0WK M6EJKK/GVN=?Q38.Y@M- X_V]7_)9,H>3$XJ$Y9 MHQ;//H>AS'9#=XWBZK/OVN9JYEJZ;@4[=T)#4 M"CU!/3L(J+!YX$N)Z:K&FKGZ/,^',MOQ]DORM@FTQ:L('\/;5=TG\/9J)Y'\ M%S@6_V0=.#'%LL;1,H/7YK"\DAG5Y@APV7D##D-SV=&;90=Z=/N)#2U[$^=Y MGNJ/O.OV,!JWQSR!^S;<5TNC*E=X$2(RZ1GC/7(2LSR?Y[Q;)R;)#Z'ZIYF; MQN&CO5 OD:OX/;'65<80(^7=7>,^U-W/UY0JO^.K[YBO%$-=5,>HE<1JC!50 MN+_W(OAF$OY8,>OVI73,JU)E@?]0&F"^-G0+=*YFPA"YN!)H4 Q@U]/.HL ]BN2AO/4?+0TGD0FLZSTU@KM59JM/7Q M[^=/YR<[UOQV63-PF6YR7:=2> ZU+&G1P/-!H]B^&7#I.P#8NJ1KK0]5Z/^> M]T1"Z5.3JA=F ;!'>.Q';*">H@&&,5E.1$R MC)+R(IHR"*79+F8X JY/:G@&J MW.:,,L?RJ OF*!>!RZ7WQ#<+[J90U7#]K, Z*:':6J>S<_BPE? M<^%YN$1^ M86;J7&$8WM;9<^Y)7K^XP9O+,5NS8E2+\,%SSYML+O9;C7@\!44CI$'W.-=2YJD0M9M M8%Y3CZ2$L;RE(LI*@8GAK&$_.:Q?4,+2)I.O\8?.?4KEW\.\B,)Q/8IJ2D'R M?[=OK$Q>6NEEDPTW$*-T>+(0+.T.BT=LG%?ANMWC-8]^O&8FTCN=MHT/A1VN M+_0[DY&M^M[&B]&W_JS(FK308P(:YX7L$[NEF:1YV PMPF,$/I;JJ-G,S8IH M:OXTCMDH/R0GRC[$G&Y2/NE&\$VWUAJ=(L_8)50"]G4T^'&A3&CUNN9QD@S1 M822E,L4!H2I.T .JR$PA^('+C,D^]H5>"$,[K+:(ZI-^^([T9"S(3905,$8\ MQB#4)S8FAE_>C#[3='8B=0\':J93W:J3AOGT%%6._PWL&0"-;)I+YK54;*3J M"GPJ%&]2$.0$%U-8;H[N<11T),,0-"IAN(N!$64Y/@&M&A7U?N3N0!'F:I7C M@)A2.QS$+R]C,64'T^!/%S3H8VI0G <.$\AB)"7L@RAL#:BNJ<[+#Z961G" M)FKG51Y22 "?96L (H!IU[NZ8#QWSC^EL G#D4Z5"9$"G>%E!KQB$=!'Z M>J8M\K$YW5#N)KF,!@HY4[2J2(6;OY(#9VE>TGK.)"84G@$*'6&ST)-\R!%X MIEY$R,9D4@*59W /7^(7@7+H(2)A,+2QZJNF 6-XK%.UOMNX]:(.A5<5%9\3 M4CZ68)=+=F8]XCD8114^NX FJ_ !]IE(]8;EU[9NFW70E3R3!=@0%UHZ/IA+7Z+7+&,.">$$0Z MRL#J^8D2HRUR!;TN10[L#-MRB"9@S..%KLR4GYU\ M4>]P8GYAV?64H)TS.^/ UAIQ$ R5OS\?!O]&T@,3,'0^X8%"8!X0,; $JE>T M*VG#!"Y$)$>+'(.E5=:+Q_,UU+3,QX=SBS'%%YN!@4?*T:7T@@I"W*])LO(I MZY$$]IR:5"%!A9;3P/>M%Z%VA.Z[AA/1+3<8PK+(*X26,5ID0YQW%9V:C1MA MK*/"?3J02647!,,[Y_+P2>_=<^_U#3$4>\RS-0!N&+!U($BGN&;YJ6I M>=^1D#W.E6V1#^-&RLS!SL&#.DTQ3*/4&AVVP!29J]I4K20E8<9XM1*JP53G M952/",<+44[W?76 ,H#NQ&"=\(I$1:^I]S]3XW'ISGRFBO M)4Y)NS!6\E+9>/>-8>0>U2^*]@#K@$3+RK8%^PH('V9J$B7:$0&P#)+*P=^0 M94[7E6&K2#H1Q=,"7&*^VU*0)PAFN(%4FQJ@!0=LRWRQ0"U5E%BHHV;6S_0* M"[.T7QJOMU&_%-^NU7()"(>XVEK,EAHMNRDL^_^.I."5.B.=R>L4<2=DSC/8 M0DP=KGZDC:2T7594>QX5DI)@\R%K@G[!13KSG R*)K /Q[@I:M[UKLW0IK5Z MSOLQ\SA G%H ]PK M8:+-Q)[ #Z_BW&GN\GFAM(&7=($^%:R'K\79^3YWOL]9WZ(W6\E[^LJ^2- M>X=-)F=-5I!0;^<*O&K)?3-7^I4713X_T?HA;I@ZBK4U?/$J&>G?Y[(YG>QM MMO0,UERTOY7C<@MO:6WIZSE#L2W6YJL=(GE-!##2RS#5$D/15-Z:_]);O:*_ MF$O"<#Z7J*X%^BU5O*BC+GB(HT0N/EPQ&VZ:S4A8-3XU,=G9;O6_Q.K7->OM M,_]WO_K7=B06X")?V+6$50E\QLI@V2DK6/E\W;X$2U"(RFM7^>G/$Y0/Y(^? M+G\E(N5#7/SO5M][3U^P:+W@/8JODY$[0_UMGO$NS?;ULT%W:;8;3+-=,XC5 M_Q'5^<\7QU>_79YU-QM-N(^&UW.#?IDZ-57&457XM708/^Y8Z8&*=Y?6 M[,&\DV%B&(\)9\-<140GP:PJQ1 04 :K,;86R!Z+PSK=4%G8506,:PTQ04%U M-\E@NAO?VL9+P)8Y+RUK6>&R,F>;XBG;(A"_@4B=[)B!VL.UC?&JQOQDA85* MA)_&3WUSY3'9:INYI_+M8;F=M\DIBV6BSG;-#ZF_&0FVC>)_!^L.UI5@;3WX M-MMFO%J+5?&4=, ;14YZD0RG4AT_J^="L_7<-M+DQ*O&'3SK%/$EKP34KY?> MFXX*\$[*CR>7&-7SW8*G_7:AE%TH9?50RE$[2,7XPU^.VKVB'W_X?U!+ P04 M " !20]M8;G<76=$, "CL@ $0 &]M:6,M,C R-# V,C8N>'-D[5U? M_'?%WO(Z]I7KG#CK<>KV[NHJQ8!FAEH&S0F(Q]]^ M)4 8@23P,)9@V3PD$Y!:W3^UI):Z:7W\>;OVP0^(0P\%QZ/#@\D(P,!!KASSR_ M;[_<7(&9LX)K&WQ"3KR&000LL(JBS=%X?'=W=^ NO"!$?AR1YL(#!ZW'P+(R MXF<8VO0Y^&1'$!Q-)]/7UN2M-7UW.WE_-)T>33\1H,BE40YM[ M["U7$7CNO "T%FD["*#OWX,++[ #Q[-],&.-O@27@7, 3GT?W-!:(;B!(<0_ MH'N0TMR&[E&8RA#9> FC+_8:AAO;@<>C3)*0H!/[]&6 UIZ3"D);GKR=OAT! M.XJP-X\C>('P^A-D4X+P" ;Q>IHW MNIUC_P#A)6UH,H;;" :A-_>A18M!G$ 76E/:@VEU(DA>F6)_]RJK/CD<__;Y M*NTG5MCW@M^YTH7F)J_&]/7<#B$K'H?6TK8W>8V%'+T4( MG8,E^C$F+[B"]*4;B22>O!FG+XM%/07#1,TBTO4YP[2?FO9?UD(%D@S PP\? M/HR3MZ.39P D"N.M-PA'(-6;*^0DO:%@C_[/8CQ:])%U.+5>'1X08B,05#1. M(>"X'1.L9W=B(E>+79E@W4I;?R-K5Z@'C5H,91I'?UCTA[+-BIX^KE'AH!A# M/PK9$R4+XC'UP((=!"A*VJ6/V,/-Q@L6*'U"GM$>.L+(A[?W&PCHCV\WE\T& MPCBRMX@\OQ_3:N,;\M=W-JNS?T\#]SR(O.C^DC2*UPDW(^"1B:=Y<<8KX]:% M9)'P$KD.)_0/64(*JTG^TPY8-(XN2U0P_(K(9.[_ MQ]N<(1OM/>"]EN5Q.*Y-9/R=(7>.O&/WP4DM&J1;EXII8/D-D]W Z#PE<3B3@ MD7]O L?L'S+BX6$=B%Q93DEG1378#OKT4,,B_USS>(TC[C>[U[,@^BS$F M?"@&NK"X)I;9 O-K;&/"AW]_ ZF-)N!65M*$=IZ1G]?X%MT%=;I9**D946J' M*&!,7FMB:0:=&!,@#J?S6[J<"]BJ%-&,UH47$O/P*\0>8"DZG2^GBHY$??,ZWSLH.EI"> M#"HF(*Z8)A;_11HF^Q@*5!QXZ;&$: (2E],ZNL^W1.>",-D-IT-".K@%1?P?&-U%*Z*'&SN0=[NXM';]_!*OY\*A5"FB ME;79"OI^'81<(:WLW=K;2Y<,"F^1S=\U,,K*ZSV 20=RNN&B]D9D1T(+65G< MB$5/IYUF]OQ#25TS*36 ,;0EQW#<:TTL49^(_W6% OGHKA31O:W-;8K:DX)* M4;V#AI@3].04.;_/5C;9WUS'$?7^48-=/G14E32?(N4'_=3A#?$57-K^-4[7 M28BAJUQ.&U;7NS2L;=__)0[)-C.4SUY\*1&#M ;U-Y-?-. "!M:W&>^6(!V' M8EQ__,MY!;[[\WR/U\A+0HF.3C)O6D;Q)4AI D(44*J99RHIW%U9B$:$\*HC M BE='^UZB2/]$B3$ <(@:Z"/ @JZKAM2EMQ![3HN(P82:H"0ZSS_@GXQ((38 MS[6GJ2Y7+$:W+_*HICNM0G&.OAU[):$!_LNH_$];)Q3]?GO2J.P'H#3!=:!/ MH=K(HM(FG0)Q/L\=.R2G 2B1SG);A%P?RRJ'[5Z6[9PP#>>U04:Z+R*532W] MTDA\U#L*D@?-Y>1 2J\'(A35RX@<$B_\GM8)2I"NT91D#Z10K1"Z1"D&'K0= M$)1&5WD5:OY3,UP.G]@1X*0N0 MP.'T^?P$8U2YS7H3; /O2F)"V*IX2!"E% MD)#LA1Q"]=>" $&"43.X+I4^QN;N]0+V1IO+MY8H&$@4!M1WDV M(@BUY .ZSO,O'-T:A> "GG9=Y%(:("7266ZYA4T;R_)XK1W1)@0MIT 1I"1! M0E.'85$,Z-IU&V)+*+5SY1 #U&U[4Q9#X8T'4PRW8*48)>9ERP4VC@OQ@NW&PH))7WZ MTH9Q >B:N9<$/[?K 4(4\%2UJ=&>Y!%TC$&AQ-'>+:.M,@,D)PI2JGV11A1[ M94 D28#[GEP3B5FHV3&QLPPJMX0>08KQ_+ON,9+#;T+CR2,HVS#+[22T<5S^ M+F%'B!,R(*&C809MRW01:KVK]D$RW/Q@5L]L5,VYBXO(V7(&T%),W0 *"'AC2=-'!?VK3< M5E%2@-'J..NBC=5C^3_%_%=2-G88"^1G#1=9B;&# @=N(BO%,JN^P&A=F\", MM8T:?0@D^XA*GQ"-+$EF-%X0T7"5CQ),BB#,N,;8K@;SFT=;G8>M/-E( ^!-"E*3G8W) MH(H9-]\/TIQM0ITO!5EW ?UB)K19ZO@)1A(:UR'-E^:N MD^B_.##.?(\(,]KQG5$-)3.ZN:O)_XX$7Q"R99UR9$Z\T MBJ51/N;%J&;*JRI]P?=CGF%1_CR>Y4I,B7FF:[+J\?RKHC#,BZ+.M5X5KS4J..>NR*_" MF^1%^7JJK 5.A">]V"E*;TPJ\\%[.#5?G-3A"V=ZD!^ZXQ<@=?#&D=Y<*].[ MM+9_JKRPO;@$I)-73?7N&H!>Y3!OXD 6#"V3%WDICODJG!JYN$)A_:G#N_ZZ M"T+-J0AJ[L**W:>Q[5]/*"E9Y< M>EH;OM& 66T7_-4$?\E8U7]A9Y-X6!FWANX/EL=[US%LY![LOV[:^=/=1MCQ MJU![? -A3Z_W[.#=PCVX>92='#3X.D9PWJ"J)1"@Z)'8B[]G8],3#LM9>7Z^ MZ6SX>8;X[!]AHK['H]V7XQ&Q;^*0,(0VE'4ZU1!1B(YCZ%ZE MJ#3^X*L7L%3\#1DN;R9#Q85W<3 X#H<.1\6]PI"9#AV9JC^'0?-JJ- \SG_$ MX'J]7[C\/B E<4LQ2-X,58-*GC"&Q]NAXB%WPC%HW@T5&K73C\'S?MCPR!R, M#)Z!F\$E9V:&RMO!&L%"#RI#9;"VL-)MR] 9K#TL]Q$S: 9K#Y=\T@R//1N\ M_<%#Y YGH S6Y&WBA&<@#=8.EKKZ&3*#-8,5L04,FX';P,50!@;)P.U>:0A% MAL^[@5O PF@-ALW [6!A< C#9N!6L" 6A2$S6"-8'?S"X!FX32P.M&'@#-8V MYL-Z&!R#M8*K(44,DL&:OY)0)H;+GDW?7OB61(%3#(\]V[V]P*,^4BM#Y_V> MK=X^HB/$9<\6;R]PJ4:=,30&:^.*H]T8+ ,W<&LB[!A*6NS<+(%!.3\ *\#R M&Y"_YG8(T\Q $**5P\BQ]$CHKN+9/_@!02P,$% M @ 4D/;6-(8\172" @#T X !O;6EC+65X,U\Q+FAT;>5;;7<:-Q;^ MW/X*;=)MTSV ;MN=Z YQP&M5W;7D)_/ M%W%1C1D_BXW7X *>MP_@J:7*2II("E/5_'_,:]0STW+G5(W,O$83/MO'$4UY M,O,F/&6:#-B4C&1*14GK2V-DZM5;AEV8*DWXF? ")@Q3>")N4)XUC;EA59W1 M@'F98M6IHEEK@8'&UPZ$TZ8\-+$7<5,-@!*.@4.^?]TXKK?:![@69,PVE;"^ MK7@*=;HL72 3J;S7=?O56B_KU%G$ETG86N)M&^%[%S'WN2$61$X#>\ 5N;TU M[AYO.\J^+1P[O=&D?]KOG$QZ9'A*3C[U!EWXGCP@0!]%'XX4C_*X 3Z"M1HR MDIB8/7=]K)/> J+7)2>#+AGUQA/ 293$7G?&PP_]3MC,OXRGO0^C2N(E=K#AML_/*&*O&="ICS09#S3AJ4:-"&"6H50$D@%%1(U7 HBU1D5<&!(J @)N^# MNC@CN0B9LK_R9^2<*Y,S(B,,2[@O4S0AG85=/M)I^7ALJ+&T79;0*56,O,%? M?__ZHEEO!*U[2,);)Z)+ 7;A:M?B#/42MGZLD.ZP-R8?>J/>NR]%O/OBK0.N M11L'(PGC'=5^.CS\YW)9\ARP?-H?C2<>F0!^!$WG"%Q$'@=\WXQXN_PD9: L M!_(1TXC1D'28 MEX4 6B!?);(Z=Z&O)-2/7L1\$(6@-NB'>>6*DWG,[#[.=?43YBU M76AQXF@+#%TN &J=^RDWQAD(GVHC@[]BT!M;C2TP%R1"H3D0N-\ A6) 66Q/ MA<@AS:6,X;%K(W'A<@F+Y@Y\U:=_/OKW33Y]_$1=&DKSX^Z8,OX@[0Y*,!H5[A$/D7W)4+ M#7L6SIJ >R**"I:!"#?5>1!?L5% MSQA^M%;OR#2%)6,,IZL+,)T7/BQS T(('+D2GJ8LY+ W9/!,<0BVA:!73;2W M2!HFX171]P!+%;1*DM@A=PK*#^##S%:GH'@2863%GLTAH'!BB&EFE=4D-GF]Q@13[APM,7S8-,VI_@H9] M1MXZ/\)7ESZM%&,&AO-@#I2 M#H(0<]P.'.=$$-XT;AXR'2CNPTG[72F/V#D4CJQ0U3A+^#[4S#5RJF1J78Q& MH-45$;7B,'#IV90$BRE%+7[4!%@&ZDVCM6(@EL;!W]5H?P/*]M7 EM$%3>R! M=8OX[F-9:M]WVO(5W).A 6ZVX[ZJV<:./5/S',5EZWD)W^50Y[*; MCH, IL"!%IT$NA$;G)?11F(*)O49$U?#[V(Q=V/=6".?@7\(L;E2V.FHPN^7 M#IH'^9"QM,13P9X52.2I[^+$9DJPTMR@!0?AW:7K1V[J@F.?/)G7,"O"E:EEJ9YY;+)B==0'/8VDTIBO(7/EC-%&Q0*)7"D!<' M;'*63=\54#+H+)"IS\7BY/'Z#G,)D0%;92VSL*'RV-\Y39!V"@O9S4F_K#*$ MO,:1+L^*,$&M.:WV>-Y/UKYR?QD3V,F'_FAA L%&]8/5[O'RPDK H!#P79] M3%M9,1LK\?6UD1N.U.U(%SN7HF>,&?AKCC,'(:&EP6H16ACH>4,J N8\8-[5 M-K&K?40,+4$([Q+9Z/;KJXR>L:J0(2O)P<@+5XVBA%U4BQ&F%!ZPFZ>B%7*= M)73FX=/6TFVD BSE=I:F"M%Q?DWI\K)2K,IC+!<^V/:OJC6O1Y,IG>E]NOKT MJ$ZPW3P$/,;EOA+N-F]")H'V5LVN9U"*L?#O'*SM\C_LF&,F!JIT^'GT>1#$:4T#A,NYV3SX%&^#UH1*.S$0\ESKNU;(GQ+ MM_M [*7;I'\Z-\E&D\S;3_7+M@?JGH6QLQU%1*31].H-0FMIC?2HAJ F7"M: MOF!M'MLWK$\YX=N>NY7RAP[L["O^0T53 MH:N:*1ZM%;7MJ[=W7_+Q5/:*FHQ@=7$OK;A[P MKP/M%XI>D*Q=Q)Q'BFKD)U>-;'1;Y+!V>'-^OHU.FD=?CZ#VL5$0\7%8Z>59 MQE1 -6L]K5N[CZO$AT'5NYFW>ZC:]L]3OMGR:*NY$.IX%],]>XLXX8+=A48. M] 'ITH0)\@GZ<*;ND\=GI;C[J2 W?@%$4_8$H7PGB6$!K&"#";Z&>)FJZ,2< M1>24"RH"3A,R=(7'-D4$L! A0#% M @ 4D/;6-(8\172" @#T X ( !7"0 &]M:6,M97@S <7S$N:'1M4$L%!@ # , N@ %HM $! end XML 15 omic-20240626_htm.xml IDEA: XBRL DOCUMENT 0001850906 2024-06-26 2024-06-26 --12-31 false 0001850906 8-K 2024-06-26 Singular Genomics Systems, Inc. DE 001-40443 81-2948451 3010 Science Park Road San Diego CA 92121 858 333-7830 N/A false false false false Common Stock, par value $0.0001 per share OMIC NASDAQ true false